MétaCan
Menu
← Back to cohort
Record W7117250300 · doi:10.1002/alz70859_098668

Combining humanized mice, neurochemical, imaging, and cognitive biomarkers for drug discovery in mice.

2025· article· en· W7117250300 on OpenAlexaff
Anoosha Attaran

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsWestern University
Fundersnot available
KeywordsDrug discoveryDrugSynucleinopathiesDrug developmentBiomarker discoveryCognitionPipeline (software)Disease

Abstract

fetched live from OpenAlex

BACKGROUND: The global population of senior citizens is growing rapidly, contributing to a rising prevalence of neurodegenerative diseases, including synucleinopathies such as Parkinson's disease (PD), Lewy Body Dementia (LBD), and Alzheimer's disease (AD). Drug development for synucleinopathies has been particularly inefficient. Progress in developing therapies targeting underlying mechanisms has been hindered by the poor translatability of animal models, which often fail to accurately reflect human synucleinopathy pathology, and the limited availability of cognitive biomarkers for predicting treatment outcomes. Our work aims to develop a comprehensive preclinical drug discovery pipeline that integrates humanized mice, neurochemical, imaging, and cognitive biomarkers to enhance predictive accuracy. This approach combines advanced behavioral assessments, imaging modalities, and real-time neurochemical monitoring in behaving mice to better understand disease pathogenesis, identify therapeutic efficacy, and detect adverse effects. METHOD: We combined preformed fibril (PFF) injections of wild-type human synuclein into mouse models expressing human synuclein with high-throughput touchscreen-based cognitive tasks relevant to synucleinopathies to investigate cognitive deficits. In parallel, fibre photometry recordings were used to measure dopamine dynamics and calcium signaling in freely behaving mice. Pathological changes were assessed using immunofluorescence, lightsheet microscopy, and MRI. We also initiated experiments to test the ability of different treatments, including drugs and genetic manipulations targeting chaperones, and a vaccine to mitigate alpha-synuclein (a-Syn) toxicity in these models. RESULT: Mice unilaterally injected with PFFs in the striatum exhibited significant cognitive deficits in touchscreen-based tasks including pairwise visual discrimination (PVD) and visuomotor conditional learning (VMCL), which appear before motor impairments. Fibre photometry recordings revealed altered dopamine dynamics in freely behaving PFF-injected mice. These cognitive and neurochemical changes were associated with elevated phosphorylated a-Syn levels that spreads through cortical-striatal-thalamic networks, confirmed through immunofluorescence, Western blotting, and lightsheet microscopy. MRI analysis showed spatial atrophy patterns in PFF-injected mice that mimic human synucleinopathy atrophy. Preliminary results indicate that treatments mitigate a-Syn toxicity and improve cognitive deficits. CONCLUSION: We aim to establish a robust cost-effective pipeline that improves the translation of preclinical discoveries to clinical success, ultimately accelerating the development of effective treatments for synucleinopathies and reducing the risk of late-stage drug failures.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.005
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.001
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0030.001
Science and technology studies0.0010.002
Scholarly communication0.0020.002
Open science0.0020.001
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0050.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.284
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicParkinson's Disease Mechanisms and Treatments→French-language works237,207→